Unique Therapeutics 2019 Investors Presentation Unique - - PowerPoint PPT Presentation

Unique Therapeutics

Changing the way we use CBD 2019 Investors Presentation

Unique Therapeutics is a biosciences company which specializes in bioavailable delivery systems and top-quality CBD products.

“CBD is viewed by many to have medical benefits, providing relief from everything from pain to depression and anxiety.”

David Reid, CNBC, 2018

• 2018 Global CBD market estimated at a

value of $300 million in 2018

• Global CBD market estimated to reach US

$2.3 billion by 2020

• Compound annual growth rate of 33.49%.

Industry Overview

Source: Forbes, Yahoo Finance

Industry Challenges

• Strong need for precision dosing and consistency of product.
• CBD is not easily absorbed into the body which reduces efficacy
• Product quality - CBD quality and content
• Navigating regulatory frameworks
• Building public and institutional trust through evidence-based information

campaigns.

• We use our specialized technology to make CBD highly

bioavailable (up to 10X) when ingested or applied

• topically. This also allows for precision dosing.
• We use pharmaceutical grade materials, equipment,

techniques and ingredients. And we have end to end quality assurance to give our customers the confidence they deserve in this market.

• We are carefully navigating the regulatory frameworks

around the world.

• We are working with the Czech government and the

international cannabis and cannabinoid institute (ICCI) to develop advisory services for authorities around the world.

Unique’s Approach

• Global reach operating in Canada, US, EU

and Brazil.

• Distribution contracts signed for India and

Singapore

• Manufacturing in Arizona currently with

monthly capacity of 5.6 million doses at 5mg

• Soon to commence manufacturing in

Ontario, Washington and Prague

Unique Therapeutics

• To manage minor afflictions such as acute

stress, sleeping disorders, or to help with focus.

• To manage major afflictions such as muscle

pain, chronic anxiety, severe stress or other hard to manage ailments

• To manage chronic issues or lifelong

disabilities such as addictions, cancer, epilepsy, symptoms of multiple sclerosis, etc.

Consumers are using CBD for the following reasons:

Client Implications: Consumers begin to rely on their favourite products. They demand consistency and quality every time.

Current CBD Product Issues

1

The current method of delivery is oil based for all cannabinoids. This is because they are derivative of the plant. The way the body utilizes these cannabinoids is inefficient.

2

Full spectrum oils may offer a benefits in their “entourage effect”, however vary in their makeup from plant to plant and is therefore an inconsistent source of relief.

3

Oil derived CBD’s absorption into the bloodstream will vary from person to

• person. Dosages must constantly be

adjusted for desired effects, making the way that the average consumer ingest cannabinoids unreliable.

4

Current methods of delivery of various cannabinoids, CBD, offer low bioavailability and are short lived in the body. These methods are therapeutically unacceptable.

• Increased bioavailability.
• Longer lasting in the body.
• Accurate dosing due to product consistency.
• Full control of chemical make up, 100% THC

free.

• Utilization of industrial hemp allows increased

liberty when dealing with regulatory hurdles.

• Addition of other biomolecules can further

increase bioavailability.

• Addition of additional non polar beneficial

biochemicals can increase product impact and value.

Use of nano lipospheres greatly increases CBD absorption when ingested, with powerful benefits:

Our Technology

We believe that CBD is a powerful tool to help consumers manage and improve both their mental and physical health and well-being.

Overall

Our techniques and process can bring a product of value to consumers that require a consistent and trustworthy supply of relief. Our nano CBD product is not only that but is also highly effective at providing real results.

Standard Dose

5mg

Is all that’s needed for one

• dose. Consumers are then

able to meter their dosages accurately

After 90 minutes

10x

Active amount of CBD in your body* after oral ingestion

Remains effective in your body for up to

6 hours

Standard CBD will be hard to detect in your bloodstream after 3.5 hours

Cherniakov et al, “The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioaviailability of delta-9- tetrahydrocannbinol (THC) and cannabidiol (CBD)...”, (25)

*Compared to oral administration of CBD oil without use of nano liposphere carrier

• -- CBD Isolate
• -- CBD Nanoliposhpere
• -- CBD, Curcumin, 2%
• Nanoliposhphere

Visualizing the Nano Advantage

CBD concentration in the blood after ingestion over time

• -- CBD Isolate
• -- CBD Nanoliposphere
• -- CBD,Piperine,

Nanoliposphere

• -- CBD + Piperine

CBD Blood concentration test #2

Including the addition of piperine

Product Overview

WE HAVE SEVERAL PRODUCTS BRANDED UNDER OUR AMARI HEMP BRAND AND WE ARE CONTINUING TO EXPAND OUR PRODUCT LINE. WE ALSO OFFER A WHITE LABELING SERVICE THROUGH OUR PRIVATE LABEL PROGRAM WE HAVE THE ABILITY TO OFFER A FULL RANGE OF PRODUCTS AND BEYOND. WE WORK WITH OUR CLIENTS TO SATISFY WHATEVER THEIR PRODUCT NEEDS MAY BE.

Amari Hemp

• Amari “Pure Hemp” is our house brand under the Unique

Therapeutics umbrella. Products already formulated and currently being formulated will fall under this category, and include

• Tinctures
• Rollerball
• Oral/Topical Spray
• Body cream

Product Strategy

Unique Product Specs

• Amari Branded Tinctures:
• 300mg CBD nano
• Wholesale Price: $29.99
• MSRP: $59.99
• Price per mg: $0.10/$0.20
• CBD Particle Size: 16.7nm
• Unique Therapeutics Bulk:
• Concentration: 20mg/ml
• Packaging: Litres or Gallons
• Price: $0.075/mg
• CBD Particle Size: 16.7nm
• Doses/Litre avg.: 4,000 doses

• Athletes
• Pets
• Healthcare Professional
• Business Professionals
• Academics
• Seniors

Market sectors

Unique will make products that are easy to use, low cost and offer real relief. Some markets our products will be

• ffered to include

The raw material that we use in our products is also available for bulk purchase by the litre or gallon. Our water-soluble product is prepared at a standard 20 mg/ml concentration. The product itself is in a water solution and is professionally processed and packaged at our GMP-compliant facility in Arizona Our bulk litres are sold at a fair markup to encourage volume purchases. Through this we intend to empower other businesses to be able to add value to their existing product line with CBD. Our spot pricing is at $0.075 per mg which allows for easy integration into an existing SKU for average $0.375 per unit (5mg standard dose)

Bulk Sales Model

The Process

The Hemp

Source the pure CBD extracted from hemp oil through farming and extraction laboratory partners.

Quality Control

Ensure that the pure CBD is passes our microbe, heavy metals, particle size, potency and other important tests to meet or exceed our quality standards.

The Process

Utilize nano encapsulation process whereby the particles are reduced in size to a nano level and then encapsulated in a liposomal carrier. From here it is packaged in our facilities and sent to wholesalers and consumers.

The UNIQUE Team

Radek Hlavacek

Radek is our company president and European delegate. Handling European affairs, Radek has an extensive history working with Canadian cannabis, focusing on growing and handling extracts. He is knowledgeable in all things European and is an expert in identifying quality plant material.

Rob Arthurs

Rob Arthurs comes from a history of working within the Canadian Government Trade Ministry. He has a passion for helping people and utilizing hemp and CBD to spread natural relief around the

• world. As our International Trade Advisor, he is well connected and well positioned to bring Unique

Therapeutics into the global spotlight.

Martin Pow

Enterprise Risk, Internal Audit, Corporate Governance, Compliance and Security Services professional with high level of innovation energy and strong leadership skills. Martin worked in the banking industry for over 20 years in organisations such as Citibank and Mizuho

• Bank. Recently a risk services Partner with Deloitte Vancouver in Canada led the successful

establishment of the new Deloitte member firm in Mongolia, holding the role of Risk and Compliance Leader for the country. First non-Mongolian to receive an “Honorary Doctor” title for Risk management contributions to the Mongolian Government and education institutions by the Mongolian National Academy of Governance University. Martin most recently returned from Dubai where he was the Global Audit risk and compliance Officer for a global group. Martin is our company Audit risk and compliance advisor and serves as our Privacy officer as we grow our business globally.

Liam Duff

Liam Duff is our science and tech expert. With a background specializing in biomedicine and nano technology, Liam has the know-how to design extraction schematics as well as best practices for nano processing and formulation. Liam is our go to expert for all things related to science and tech.

Mohsen Jahanshahi

Mohsen is our sales and operations director, handling all things related to logistics, packaging, operational flow and sales channels. Coming from a variety of backgrounds, Mohsen brings his expertise in way of superb relationship management, methodical control

• f operations and overall management of company needs.

Current Projects

We are currently working on a range of projects around the

• world. Any discussion of

investment would be allocated towards progressing the missions we are currently engaged in

Clinical Trials

Through connections in Czech Republic hospital, we are looking at arranging clinical trials for our CBD nano in hospitals. This will be made available to doctors with results documented in a clinical study to gauge the effectiveness of our product with regards to topical ailments Through partnerships and connections into the Brazilian and South American market, we are aiming to engage in clinical trials for efficacy of

• ur product in treating topical ailments. This will

be a clinical trial with standards equivialent to USA grade trials.

Canadian Licensing Project

• We are in talks with several entities in order

to arrange a license to be brought upon our

• peration. We would like to bring our CBD

nano into the Canadian medical market to be distributed through a licensee to patients and doctors that are interested in utilizing

• ur product for a variety of reasons;
• Anxiety
• Pre/Post Op inflammation control
• Anti inflammatory for joint and muscles
• Alzheimers research
• Pain management

USA Hemp- Derived CBD

• We currently have space and operate out of

Phoenix, Arizona, where we have a 1400L/month capacity nano emulsifying

• machine. In this facility we have access to drop-

shipping services and packaging arrangements to ensure our product can be produced and immediately packaged into whatever desired product.

• Our next phase of operations is to bring our

company into a licensed facility in Sedro Wooley, Washington, where we can make our product in a legal framework and have enhanced flexibility in movement of our CBD nano.

Czech Republic

• Our president Radek Hlavacek has been

hard at work in the Czech Republic receiving imported CBD nano intracompany to set up packaging and distribution within the EU. This pipeline enables our product to be distributed wherever hemp is allowed within the EU, which is the majority of countries.

• Our main priority in this market is the

distribution of topical delivery methods for

• ur CBD nano, as our product specializes in

transdermal application in addition to beverage formulations.

Other Partnerships

Through various partnerships and business arrangements we are engaged in early stage negotiations with interests in the following countries: United States Canada India Spain Amsterdam Jamaica Ireland United Kingdom

Funding

Company founders currently own 100% of the company We are fully self funded and have done everything in

• house. Any investment made into our company would

go towards advancing certain areas that need growth;

Marketing Materials

• Professional grade

marketing material to be distributed to our resellers and used to promote our brand

Inventory

• An investment into

building our inventory

• f the range of

products we would like to offer immediately is a priority for us

Packaging

• We would like to

expand beyond our 2 SKUs to bring the remaining 3 to a reality. This would involve a round of packaging, design and printing efforts

Trade Missions

• Funding trade missions will

allow us to be boots on the ground and explain our product and sales strategy. From there we will have educated personnel in those areas that will continue to grow our business.